Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities. Obstructive sleep apnea syndrome (OSAS), on the other hand, is usually ...
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Global Lung Function Initiative (GLI) have published a joint statement on the use and interpretation of spirometry for the ...
Merck (NYSE:MRK) is approaching phase 2 data for Winrevair in pulmonary hypertension. Results will focus on the 6 minute walk ...
Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company’s high-value CyPath® Lung test Number of CyPath® Lung tests performed in 2025 increased ...
A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.
Distinct COPD phenotypes show differences in severity and mortality, with worse outcomes linked to income, race, rural living, and smoking.
A retired teacher who smoked every day for more than 60 years says a shock diagnosis finally forced him stop - after doctors ...
Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...
Healthcare professionals note that the best way to prevent lung damage due to cigarette smoke is quitting smoking and early detection of these symptoms. Check out early warning signs: ...
The research was led by a team from Simon Fraser University (SFU)'s Aerospace Physiology Laboratory, which routinely ...
InvestorsHub on MSN
BioAffinity Technologies posts 2025 results as CyPath lung testing growth accelerates
Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results